loading

Day One Biopharmaceuticals Inc Azioni (DAWN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
34.99%
53.72
39.80 33.91 30.76 29.21
Operating Expenses
26.75%
81.18
64.05 68.88 71.83 94.54
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
26.75%
81.18
64.05 68.88 71.83 94.54
Operating Income/Loss
13.22%
-27.46
-24.25 -34.97 -41.07 -65.33
Nonoperating Income/Loss
7.09%
4.204
4.525 4.652 5.071 6.092
Income/Loss From Continuing Operations Before Tax
34.99%
53.72
39.80 -30.32 -36.00 29.21
Income Tax Expense/Benefit
-1.976
- - - 6.474
Income/Loss From Continuing Operations After Tax
632.19%
-211.79
39.80 -30.32 -36.00 -6.474
Net Income/Loss
-107.32
- -30.32 -36.00 -6.474
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
536.20%
-86.04
19.73 30.32 36.00 59.24
Basic Average Shares
99.86%
0.1497
103.38 103.07 102.71 3.0693
Diluted Average Shares
99.86%
0.1497
103.38 103.07 102.71 3.0693
Basic Earnings Per Share
10.53%
-0.21
-0.19 -0.29 -0.35 -0.69
Diluted Earnings Per Share
10.53%
-0.21
-0.19 -0.29 -0.35 -0.69
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):